TickerFacts.

Zhengye Biotechnology Holding Ltd (ZYBT): Capital Expenditures

Annual figures by period end, from SEC filings.

1.01M CNY
Year ended 2025-12-31
-66.7%
3-year compound annual growth
27.33M CNY2022-12-31: 27.33M CNY2023-12-31: 7.40M CNY2024-12-31: 13.59M CNY2025-12-31: 1.01M CNY1.01M CNY
2022-12-31 Capital Expenditures (CNY) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-311.01M CNY-92.6%2026-04-28, From 2025-01-01
2024-12-3113.59M CNY+83.7%2026-04-28, From 2024-01-01
2023-12-317.40M CNY-72.9%2026-04-28, From 2023-01-01
2022-12-3127.33M CNYn/a2025-07-03, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Zhengye Biotechnology Holding Ltd (ZYBT)2025-12-311.01M CNY-92.6%
Yatsen Holding Ltd (YSG)2025-12-3142.06M CNY-20.2%

Compare ZYBT, YSG side by side · Screen every company in Pharmaceutical Preparations ↗